Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy

Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy

Item
http://www.wikidata.org/entity/Q28212833
Efficacy and safety of individually tailored antiplatelet therapy in patients with acute coronary syndrome after coronary stenting: a single center, randomized, feasibility study.Evaluation of clinical risk factors to predict high on-treatment platelet reactivity and outcome in patients with stable coronary artery disease (PREDICT-STABLE).Platelet function testing and implications for clinical practice.Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.Antiplatelets in acute coronary syndrome: personal perspectives.Determinants to optimize response to clopidogrel in acute coronary syndromeeNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment.PFA-100-measured aspirin resistance is the predominant risk factor for hospitalized cardiovascular events in aspirin-treated patients: A 5-year cohort study.Von Willebrand factor antigen predicts response to double dose of aspirin and clopidogrel by PFA-100 in patients undergoing primary angioplasty for ST elevation myocardial infarction.
P2860

Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy

Item
http://www.wikidata.org/entity/Q28212833
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@ast
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@en
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@nl
type
label
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@ast
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@en
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@nl
prefLabel
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@ast
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@en
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Residual platelet reactivity i ...... I on dual antiplatelet therapy
@en
P2093
P304
P31
P356
10.1016/J.ATHEROSCLEROSIS.2007.04.048
P407
P433
P478
P50
P577
P698